Bioequivalence & Bioavailability International Journal (BEBA)

ISSN: 2578-4803

Review Article

Current and Future Challenges for Vaccine Development Especially COVID-19

Authors: Yousaf Khan*, Zia-Ur-Rehman, Hakimullah, Abdul Sattar, Syed Amin Ullah, Madeeha Bibi and Saifuddin

DOI: 10.23880/beba-16000181

Abstract

Global health has been greatly impacted by vaccines. Smallpox, rinderpest, and several other major infections have been eradicated. A variety of infectious diseases of childhood have been significantly improved by whom in the past decade. As polio has been virtually eradicated, and measles has been controlled successfully, it may also be eradicated soon. Vaccines can prevent infections such as pneumonia and diarrhoea which cause 6.6 million deaths each year. Due to new pneumococcal conjugate vaccines and rotavirus vaccines, childhood mortality is expected to decline further. As of now, malaria, tuberculosis, and HIV vaccines have had modest success. Vaccinations that stimulate different immune systems and it may be the most effective way to prevent these infections. On a long-term basis, vaccines may prevent or modulate diseases other than infectious diseases. It is already possible to develop cancer vaccines, and in the future it will be possible to develop vaccines for addictions, diabetes, hypertension, and Alzheimer's disease as well.

Keywords: Vaccine Development; Challenges; Global Health Problems

View PDF

Google_Scholar_logo Academic Research index asi ISI_logo logo_wcmasthead_en scilitLogo_white F1 search-result-logo-horizontal-TEST cas_color europub infobase logo_world_of_journals_no_margin